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To examine the genetic basis of age-related macular degeneration (ARMD), a degenerative disease of the retinal
pigment epithelium and neurosensory retina, we conducted a genomewide scan in 34 extended families (297
individuals, 349 sib pairs) ascertained through index cases with neovascular disease or geographic atrophy. Family
and medical history was obtained from index cases and family members. Fundus photographs were taken of all
participating family members, and these were graded for severity by use of a quantitative scale. Model-free linkage
analysis was performed, and tests of heterogeneity and epistasis were conducted. We have evidence of a major
locus on chromosome 15q (GATA50C03 multipoint ; empirical ; single-point57 55Pp 1.98# 10 P  1.0# 10
). This locus was present as a weak linkage signal in our previous genome scan for ARMD, in the57Pp 3.6# 10
Beaver Dam Eye Study sample (D15S659, multipoint ), but is otherwise novel. In this genome scan, wePp .047
observed a total of 13 regions on 11 chromosomes (1q31, 2p21, 4p16, 5q34, 9p24, 9q31, 10q26, 12q13, 12q23,
15q21, 16p12, 18p11, and 20q13), with a nominal multipoint significance level of or LOD1.18. Family-P  .01
by-family analysis of the data, performed using model-free linkage methods, suggests that there is evidence of
heterogeneity in these families. For example, a single family (family 460) individually shows linkage evidence at 8
loci, at the level of . We conducted tests for heterogeneity, which suggest that ARMD susceptibility lociP ! .0001
on chromosomes 9p24, 10q26, and 15q21 are not present in all families. We tested for mutations in linked families
and examined SNPs in two candidate genes, hemicentin-1 and EFEMP1, in subsamples (145 and 189 sib pairs,
respectively) of the data. Mutations were not observed in any of the 11 exons of EFEMP1 nor in exon 104 of
hemicentin-1. The SNP analysis for hemicentin-1 on 1q31 suggests that variants within or in very close proximity
to this gene cause ARMD pathogenesis. In summary, we have evidence for a major ARMD locus on 15q21, which,
coupled with numerous other loci segregating in these families, suggests complex oligogenic patterns of inheritance
for ARMD.
Introduction
Age-related macular degeneration (ARMD) is the most
common cause of severe visual disability and blindness
in the United States and other developed countries (Jon-
asson and Thordarson 1987; Vinding 1990; Klein et al.
1992; Balatsoukas et al. 1995; Attebo et al. 1996; Evans
and Wormald 1996; VanNewkirk et al. 2000; Buch et
al. 2001; VanNewkirk et al. 2001; Harvey 2003). The
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prevalence of ARMD in the population aged 165 years
is 9% and reaches 28% in those aged 175 years (Klein
et al. 1992, 1997, 1999). Early ARMD is manifested by
large soft drusen, with progression to either geograph-
ic atrophy or neovascularization in late ARMD. The
atrophic form involves modifications in pigment distri-
bution, loss of retinal pigment epithelium [RPE] cells
and photoreceptors, and reduced retinal function due to
an overall atrophy of the cells. The prominent features
of the neovascular form of ARMD involve proliferation
of abnormal choroidal vessels, which enter the Bruch’s
membrane and RPE layer into the subretinal space,
thereby resulting in detachments of the sensory retina
or RPE, hemorrhage, exudates and glial proliferation
with scarring. The molecular basis of this disease is not
known and the presence of specific lesions described
above are used to characterize its presence and severity
and to tailor treatment for advanced stages of the dis-
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ease. Antioxidants and vitamin supplements have been
shown to lower the incidence of progression to late
stages of ARMD from 29% to 21% (Anonymous 2001).
Established treatment options for the neovascular forms
of the disease, photocoagulation and photodynamic
therapy, have also been shown to have some benefit to
a limited number of persons with this condition (Bressler
2002; Hunt and Margaron 2003; Mittra 2003). A sig-
nificant number of persons with this condition, despite
available interventions, will progress to severe visual
loss. Understanding the pathophysiology of this disease
should aid in designing more universal and effective
treatment.
Risk for ARMD development is associated with nu-
merous environmental factors, such as smoking (Klein
et al. 1993, 1998b, 2002b; DeBlack 2003), sunlight
exposure (Cruickshanks et al. 1993), and diet (Sed-
don et al. 1994; Mares-Perlman et al. 1996; Vanden-
Langenberg et al. 1998; Jacques 1999; Anonymous
2002). Observational studies of these risk factors have
not given consistent results; nor do they fully explain
the excessive familial clustering of ARMD. Several lines
of evidence have convincingly established the impor-
tance of genetic factors in the etiology of ARMD, in-
cluding twin (Hammond et al. 2002) and family studies
(Keverline et al. 1998; Yoshida et al. 2000; Stone et al.
2001), population-based genetic epidemiologic studies
(Klein et al. 2001a), and segregation analyses (Heiba et
al. 1994). Comparison of casewise concordance in 226
MZ and 280 DZ twin pairs showed higher concordance
rates among MZ (0.37) versus DZ (0.19) twins (Ham-
mond et al. 2002). Examination of sibling correlations
for ARMD quantitative scores in 564 sibships in the
Beaver Dam Eye study (Heiba et al. 1994) showed sig-
nificant correlations. Further modeling and parameter
fitting suggested that single major gene segregation
could explain 89%–97% of the genetic variability or
55%–57% of the total variability.
A number of genes implicated in other morphologi-
cally distinct forms of macular degeneration (Allikmets
1997b; De La Paz et al. 1997; Rivera et al. 2000; Gorin
2001; Guymer et al. 2001, 2002; Bernstein et al. 2002)
have been investigated in ARMD, but no consistent as-
sociations have emerged. More recently, several ge-
nomewide scans (Klein et al. 1998a; Weeks et al. 2000;
Weeks et al. 2001; Majewski et al. 2003; Schick et al.
2003) for ARMD have been conducted and analyzed
using both model-free and model-based linkage meth-
ods. Novel ARMD loci on chromosomes 1q31, 3p13,
4q32, 9q33, 10q26, 12q23, and 17q25 were identified
in these scans. The loci on chromosomes 1q31 and
10q26 were observed in independent scans (Klein et al.
1998a; Weeks et al. 2001; Majewski et al. 2003) and
are the only loci that have been validated, thus far, for
ARMD. On the basis of these results, it is apparent that
the phenotypic and genetic heterogeneity of ARMD is
complex.
To further comprehend the genetic basis of ARMD,
we have undertaken a genome scan of extended families
identified from the Retinal Clinic at the University of
Wisconsin. In contrast to our previous genome scan
(Schick et al. 2003), which was performed on a sample
of small families from Beaver Dam, WI, with all grades
of ARMD from early to late but with a small bias to-
wards higher grades, the families in this second sample
(FARMS, for “Family ARM Study”) were larger and
were ascertained through probands with severe ARMD.
To fully utilize the data available, analysis was per-
formed on a quantitative scoring system that represents
the full spectrum of severity of ARMD lesions. Com-
pared with assignment of binary affection status based
on clinical criteria or a threshold value, use of quanti-
tative scores reduces the corresponding probability of
misclassification of individuals and may provide in-
creased power to detect linkage signals. Although the
data could be dichotomized for analysis, for comparison
with previous analyses of ARMD, no single dichotomy
would correspond to all such previous analyses. In
regions that gave evidence suggestive of linkage, we an-
alyzed candidate genes that have been associated else-
where with other forms of macular degeneration.
Subjects, Material, and Methods
Subject Recruitment and Evaluation
Families.—Thirty-four index cases and their families,
visiting the Retinal Clinic at the University of Wisconsin,
were invited to participate in a study of genetic correlates
for ARMD. The index cases were people with advanced
ARMD. All consenting subjects and family members
were interviewed using a uniform interview schedule and
had fundus photographs taken. Family members who
lived at remote sites were sent to local clinics for blood
draws and photographs. Fundus photographs were
graded using a codified grading scheme that is briefly
described below. The protocol for phlebotomy and sub-
ject testing was approved by the Institutional Review
Board at the University of Wisconsin.
Phenotypic evaluation.—Stereoscopic photographs of
the retina were graded using standardized protocols to
detect and classify the presence and severity of ARM
lesions (Klein and Klein 1991; Bird et al. 1995; Klein et
al. 1991a, 1991b, 1991c, 1997). Details of the grading
procedure have been described elsewhere (Klein et al.
1991a, 1991b).
Two gradings were performed for each eye (Klein and
Klein 1991, 1995; Klein et al. 1991a, 1991b, 1992,
1997, 2001b, 2002a). First, a preliminary masked grad-
ing was done by one of two senior graders. Next, de-
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tailed gradings were performed by one of three other
experienced graders. For detailed grading, each eye was
graded independently of the other. The assessment con-
sisted of a subfield-by-subfield, lesion-by-lesion, evalu-
ation of each photograph set using the Wisconsin Age-
Related Maculopathy Grading System (Klein et al.
1991a, 1991b). Next, a series of edits and reviews was
performed. Standardized edit rules were used to adju-
dicate disagreements (Klein et al. 1991a, 1997).
A 16-level (0–15) severity scale based on drusen size,
type, and area; pigmentary abnormalities; geographic
atrophy; and signs of exudative macular degenera-
tion was constructed. The ordering of the scale was
based on associations of the presence and absence of
early signs of age-related maculopathy with the inci-
dence of geographic atrophy or exudative macular de-
generation (Klein and Klein 1995).
An average score was calculated from scores of both
eyes. However, if a score was missing for either eye,
the score for the available eye was substituted for the
missing score (this occurred for 2.42% of the subjects
participating in the study). We used multiple regres-
sion analysis to investigate the effects of age, age2,
smoking, and sex, along with their interactions. As a
result, we found that age and age2 were the only sig-
nificant terms in the variation of the maculopathy in
this sample, assuming independence among subjects.
We first calculated residuals from the regression
model, as follows: ARMDresidual p (ARMDleft eye 
ARMDright eye)/2  13.62391  0.51210 # age 
0.00581 # age2. These residuals were utilized as indi-
cated below in the linkage analysis.
Molecular Methods
Genome scan.—High molecular weight DNA was iso-
lated from buffy coats (Miller et al. 1988) and 381 mark-
ers on 22 autosomes were genotyped in 349 sib pairs
from 34 extended families. We used the Weber Set 10
microsatellite marker set, which has an average marker
spacing of 8.85 Kosambi cM. Two additional markers,
D1S406 and D1S236, in close proximity to the ABCA4
(retina-specific ABC transporter) gene were also geno-
typed. This gene is mutated in one form of Stargardt
disease (STGD) and was hypothesized to be a candidate
gene for ARMD (Allikmets et al. 1997a, 1997b; Allik-
mets 2000).
After extracting DNA from the blood samples, we
used a fluorescence-based genotyping method for the
genome scan. PCR primers conjugated with fluorescent
dyes were purchased from IDT technology and Applied
Biosystems. Genomic DNA (at 10 ng/ml, 3 ml) was PCR
amplified using 0.225 U Platinum Taq DNA Polymerase
(Gibco), Tris-HCl (200 mM, pH 8.4), dNTPs (200 mM
each), MgCl2 (1.0–3.0 mM), and forward and reverse
PCR primers (0.2 mM). The final reaction volume was
12 ml and the reactions were carried out in 96-well plates
on an MJ Research Tetrad DNA Engine. The amplifi-
cation reactions were optimized for the fluorescent dye-
labeled primers, using the published conditions as the
initial value. Eight to 10 markers were pooled after PCR,
to create multiplexed panels. The multiplexed markers
were run on an ABI 3700 capillary machine (Applied
Biosystems). Five percent of the sample were blindly rep-
licated, and two Centre d’Etude du Polymorphisme Hu-
main (CEPH) controls were also included on each gel,
to serve as internal controls. The ABI ROX 500 standard
(present in every lane) was used to estimate the size of
alleles.
Fine mapping.—After reviewing the initial outcome of
the genome scan, regions on chromosomes 1q, 12q, and
15q that showed interesting results were followed up by
typing additional markers. Thus, 4 markers on chro-
mosome 1, 25 markers on chromosome 12, and 14
markers on chromosome 15 were also genotyped, de-
creasing the average intermarker distance at these lo-
cations to 3.13, 3.40, and 2.86 cM, respectively. The
markers on chromosome 1q21-35—D1S466, D1S202,
D1S2625, and D1S413—covered a 26-cM region pre-
viously linked to an autosomal dominant locus for a dry
type of ARM (Klein et al. 1998a). The region on chro-
mosome 12q was in close proximity to the linkage signal
in our prior genome scan (Schick et al. 2003).
Molecular analyses of candidate genes.—As described
in the “Statistical Methods” section that follows, we
performed model-free linkage analyses of all the families
jointly to identify regions with P values !.01, followed
by individual analysis of the larger families to determine
which families contributed to particular linkage signals.
On the basis of these analyses, we identified three fam-
ilies contributing to the chromosome 1q signal and
three families contributing to a chromosome 2p signal.
Candidate genes hemicentin-1 (Ensembl transcript ID
ENSG00000143341) and EGF-containing fibulin-like
extracellular matrix protein 1 (EFEMP1 [MIM 601548])
on chromosomes 1q31 and 2p16, mutated in a dry form
of ARM (Klein et al. 1998a; Schultz et al. 2003) and in
Malattia Leventinese and Doyne honeycomb dystrophy
(Stone et al. 1999; Guymer et al. 2002), respectively,
were targeted for analysis.
To determine whether or not the previously described
mutation in codon 5345 of the hemicentin-1 gene, re-
sulting in conversion of a glutamine to an arginine, was
present among family members, primers were designed
to amplify exon 104 (forward primer 5′-tttcttttttatatcat-
ggc-3′; reverse primer 5′-cacatactttgatcagtaag-3′). Stan-
dard conditions were used for PCR amplification, fol-
lowed by purification of the product with an ExoSAP-IT
(USB Corporation) treatment to remove the residual
primers. The purified amplicons were subjected to au-
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tomated sequencing with the BigDye terminator kit, us-
ing the forward primer, and were run on the ABI 3700
to identify the mutation.
Individuals with ARMD scores 112, clinically consid-
ered equivalent to the end stages of ARMD with geo-
graphic atrophy or neovascular disease, were selected
from three families that were linked to chromosome 2.
Primers spanning each of the 11 exons in EFEMP1 were
used to amplify the DNA from these individuals, using
previously described conditions (Stone et al. 1999). The
resulting products were purified with ExoSAP-IT (USB
Corporation) and were subjected to automated sequenc-
ing to identify mutations in EFEMP1.
We also genotyped four SNPs in the hemicentin-1 gene
and two SNPs in the EFEMP1 gene. A Taqman assay
(Assays on Demand, Applied Biosystems) was used to
interrogate each SNP in a final volume of 25ml using
manufacturer’s protocols. The following SNPs were
genotyped: in hemicentin-1, rs1475113 in intron 4,
rs743137 in intron 36, hCV625089 in intron 86, and
rs680638 in intron 105; and, in EFEMP1, rs1430193
in intron 4 and rs2277887 in intron 2.
Statistical Methods
Error checking and relationship testing.—Inconsis-
tencies in the segregation of the genotypes within fam-
ilies were examined using MARKERINFO (S.A.G.E.
v4.4). Individuals who demonstrated Mendelian incon-
sistencies at multiple markers that could not be resolved
by retyping were treated as missing for the purpose of
this analysis. In total, 0.24% of the data were treated
as missing. We also checked the marker data for any
significant departures from Hardy-Weinberg propor-
tions. We then established the allele frequencies for each
genetic marker by simple gene counting (disregarding
relationships). Critical results were also verified by com-
paring them with the maximum likelihood estimates of
the allele frequencies obtained using the S.A.G.E. pro-
gram FREQ.
Prior to performing the linkage analysis, we reclas-
sified the sib pairs in each pedigree according to their
likely true relationship, utilizing the S.A.G.E. program
RELTEST. RELTEST classifies relationships by using a
Markov process model of allele sharing along the chro-
mosomes (Olson 1999). The probability of misclassifi-
cation depends on the total length of the genome scan
and overall marker informativeness. It is possible for
individual pairs to be misclassified if one or both mem-
bers have a high proportion of missing genotypes. We
reclassified four individuals in three full sibships as half-
sibs, and three individuals in three full sibships as un-
related, and hence their data were deleted. There was
only one reclassification in which one member of a sib-
pair had as much as 10% missing data.
Linkage analyses.—The power of a model-free quan-
titative trait linkage analysis depends on the scale of
measurement (Wilson et al. 1991). In order to perform
a Box-Cox power transformation of the data (Box and
Cox 1964), all the measurements must be positive. For
this reason, we adjusted the scores to age 80, as did
Heiba et al. (1994), by adding 13.62391 0.51210#
to the residuals obtained from the280 0.00581# 80
regression analysis on age and age2. This resulted in 18
of the age-adjusted scores being 115, the highest score
in the revised ARM scoring system. Therefore, these 18
age-adjusted scores were winsorized, replacing them
with the 19th-largest score. One age-adjusted score was
negative and was replaced with zero.
A commingling analysis was performed to compare
the distribution of the age-adjusted scores for the
FARMS data with that of Beaver Dam data (Heiba et
al. 1994), using the program SEGREG in S.A.G.E.. It
was found that a two-mean model similar to that for
the Beaver Dam data fitted the best; the estimate of the
power transformation was 0.80, similar to that (0.76)
for the Beaver Dam data. Therefore, the age-adjusted
scores were raised to the power of 0.80 prior to linkage
analysis.
Genotypes from all family members were used to cal-
culate multipoint identity by descent (IBD) allele sharing
distributions using the GENIBD program of S.A.G.E..
SIBPAL, a model-free S.A.G.E. linkage program was
then used in our study to perform the linkage analysis
using all possible sib pairs. Evidence for linkage was
evaluated by a Haseman-Elston regression (Haseman
and Elston 1972; Elston et al. 2000) as implemented in
SIBPAL, using the newest adaptation of the method,
which transforms the sib pair’s trait values to a weighted
combination of the squared trait difference and squared
mean corrected trait sum, allowing for the noninde-
pendence of sib pairs (W4 option) (Shete et al. 2003).
Apart from relative ease of analysis, an advantage of
restricting the analysis to full-sibling relationships (other
than to calculate the allele sharing by pairs of sibs) is
the ease with which valid P values can then be obtained
by a permutation test that fully allows for the correla-
tional structure of the data. Thus, all multipoint results
that were nominally significant were verified by com-
parison to the null permutation distribution, using a
sample of up to 100,000 replicate permutations of the
allele sharing data, the permutation being both within
sibships and across sibships of the same size, as imple-
mented in SIBPAL. Multipoint empirical P values are
reported in the results for specific marker locations. We
should note that these empirical P values are not cor-
rected for multiple testing but can be interpreted as ge-
nomewide significance levels following the locus-count-
ing method of Wiltshire et al. (2002). Linkage analyses
were performed for all 34 families jointly, followed by
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Table 1
Descriptive Statistics for Probands and Other Relatives in the 34
Families with ARMD
Family
Members N % Male
Average Age at
Diagnosis [SD]
(years)
Average ARMD
Score [SD]
(years)
Probands 34 23.5 78.7 [5.33] 13.10 [1.65]
Sibs of proband 85 38.8 73.7 [8.66] 7.69 [4.39]
Others 178 47.2 54.4 [11.63] 2.93 [2.09]
independent analysis of each of the 18 largest families
to identify families linked to specific chromosomal lo-
cations. Of these families, 13 were included in the tests
for heterogeneity, but all 34 families were used to test
for epistasis.
Analyses to identify heterogeneity and epistasis.—To
formally confirm findings of linkage heterogeneity, tests
of statistical interaction were conducted between a fam-
ily effect and allele sharing in regions showing evidence
for linkage in the 13 families containing at least 5 sib
pairs (the number of sib pairs in a family ranges up to
76). The test of statistical interaction was done by fitting
(1) a reduced regression model that included the main
effect of allele sharing at a location, along with an in-
tercept and 12 family effects, and (2) a full regression
model that also included the 12-family effect by allele-
sharing interaction terms. Equivalently, the reduced
model includes a separate intercept for each family (as
13 nuisance parameters), together with a single common
regression on allele sharing (a total of 14 parameters),
whereas the full model includes these same 13 intercepts
and regression on allele sharing for each of the 13 fam-
ilies (26 parameters), thus allowing for linkage hetero-
geneity. Denoting the residual sum of squares SSER and
SSEC for the reduced and full models, respectively, and
MSEC for the mean square error for the full model, the
test statistic has an F-dis-(SSE  SSE )/(12#MSE )R C C
tribution with numerator and denominator df 12 and
n26, respectively, where n is the number of sib pairs,
if the sib pairs are independent. Because the sib pairs
are not independent, we take the denominator df to be
the effective number of independent sib pairs 26,
where the effective number of independent sib pairs was
taken to be the number of sibs minus the number of
sibships (Wilson and Elston 1993). It should be noted
that when a weighted average of the squared trait dif-
ference and the squared mean-corrected trait sum is used
as the dependent variable in the Haseman-Elston re-
gression (Shete et al. 2003), the weights depend on the
model that is fitted, with the result that the dependent
variable changes with the model. To avoid this difficulty,
all heterogeneity tests were performed using the mean-
corrected trait cross-product (Elston et al. 2000) as the
dependent variable. For all seven regions where the over-
all P value was !.002 for linkage analysis, we initially
tested for heterogeneity at the most significant location.
Whenever the P value of the heterogeneity test was !.01,
surrounding points were further tested for heterogeneity.
We tested for epistatic interaction between locations
on two different chromosomes using a new Haseman-
Elston regression analysis model that included the prod-
uct of the estimated proportions of alleles shared at each
location. We did this using a full model that included
the interaction term in addition to an intercept and the
two main effects—that is, the estimated proportions of
alleles shared at each location. To demonstrate that a
negative result for such a test should not be interpreted
as an indication that epistasis is not present, we also
compared the full model with a model that included only
an intercept and the interaction term.
Analysis of hemicentin-1 and EFEMP1 SNPs.—To
eliminate a gene as a candidate gene for ARMD, a link-
age analysis was carried out incorporating the SNPs
within the gene as covariates in the new Haseman-Elston
regression analysis. The purpose of this was to see
whether the significance of linkage to ARMD was re-
moved by adding the covariates into the regression
model (Fulker et al. 1999). A full covariate model was
initially constructed that included 6 covariates for each
SNP: the mean-corrected sum, the difference and the
mean-corrected cross-product of each of the dummy var-
iables that coded the dominant and additive effects of
the SNPs in the gene. Covariates resulting in unstable
estimates because of extreme colinearity were eliminated
from the regression equation. The final model included
all the additive terms but no dominance terms, which
destabilized the models.
For multiple SNPs in a candidate gene that accounted
for all the linkage evidence, we used two ways to de-
termine the haplotype of length n associated with high
values of the trait ( ,2,3,4) from the results thatnp 1
yielded the largest P value indicated for each value of
n. First, we looked at the sign of the coefficient of the
additive effect sum in the Haseman Elston regression
analysis; a positive sign would indicate association with
the allele coded 2 in homozygotes and a negative sign
would indicate association with the allele coded 0 in
homozygotes (all heterozygotes were coded 1). Second,
characterizing each allele by its additive effect, so that
there are two effects associated with each SNP, we ex-
amined the possible haplotype effects for n SNPs andn2
chose the haplotype with the largest effect.
Results
The data set for FARMS comprise 34 extended pedigrees
with a total of 297 individuals and 349 sib pairs. The
average number of individuals per pedigree  SD was
12.18  7. 57, with a minimum of 4 and a maximum
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Figure 1 Multipoint results of the genomewide linkage scan for ARMD, using the Weber Panel 10 map spacing on 22 autosomes. For
each chromosome, genetic distance (cM) is plotted on the X-axis against (P value) on the Y-axis.pPp  log10
of 46 individuals. There were 100 sibships with an av-
erage size of 2.80  1.77, with a minimum of 1 and a
maximum of 9 individuals. As described earlier, families
were ascertained through probands who had late-stage
disease. The average ARMD score  SD for the pro-
bands was 13.1  1.65 (table 1). Of the 34 families,
22 had at least one other sib with a score 112 in at least
one eye.
Genome Scan
The results of the full genome scan are presented
in figure 1. We observed 13 regions on 11 chromo-
Table 2
Genetic Locations and Multipoint P Values for Markers and
Interpolated Locations Showing Possible Linkage (P  .01) on
Chromosomes 1, 2, 4, 5, 9, 10, 12, 15, 16, 18, and 20 for ARMD
Chromosome and
Location (cM) Marker P Value
Chromosome 1:
194 .0077
196 .0052
198 .0054
200 .0083
Chromosome 2:
54 .0096
56 D2S1788 .0065
58 .0019
60 7.8 # 104
62 6.7 # 104
64 D2S1356 .0011
66 .0015
68 .0023
70 .0039
72 .0066
76 .0050
78 .0024
80 .0014
82 .0011
84 .0011
86 .0014
87 D2S441 .0016
88 .0013
90 .0016
91 D2S1394 .0023
92 .0020
94 .0016
96 .0016
98 .0023
100 .0041
102 .0085
264 .0094
265 D2S2986 .0054
Chromosome 4:
0 D4S3360 .0065
2 .0084
Chromosome 5:
162 .0078
164 .0037
166 .0018
168 .0011
170 .0010
172 .0012
174 .0017
175 D5S1456 .0021
176 .0026
178 .0049
Chromosome 9:
0 D9S1779 .0057
2 .0026
4 .0018
6 .0020
8 D9S1871 .0032
10 .0028
12 .0036
14 .0069
(continued)
Table 2 (continued)
Chromosome and
Location (cM) Marker P Value
Chromosome 9 (continued):
16 .0060
18 .0069
102 .0090
104 D9S910 .0066
106 .0052
108 .0045
110 .0044
111 D9S938 .0045
112 .0033
114 .0022
116 .0019
118 .0024
120 D9S930 .0038
Chromosome 10:
158 .0072
160 .0045
162 .0031
164 .0024
165 D10S1248 .0022
166 .0017
168 .0012
170 .0013
171 D10S212 .0015
Chromosome 12:
48 .0080
49 D12S1042 .0056
50 .0059
52 .0079
62 .0088
64 .0071
65 D12S297 .0066
66 .0072
68 .0092
122 .0089
124 .0082
125 D12S2070 .0082
126 .0065
128 .0042
130 .0029
132 .0025
134 .0026
136 .0033
137 D12S395 .0039
138 .0031
140 .0021
142 .0015
144 .0012
146 .0012
148 .0014
150 D12S2078 .0019
152 .0037
154 .0085
Chromosome 15:
22 .0037
24 5.9 # 104
26 6.8 # 105
28 7.8 # 106
30 1.3 # 106
(continued)
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Table 2 (continued)
Chromosome and
Location (cM) Marker P Value
Chromosome 15 (continued):
32 3.9 # 107
34 2.2 # 107
35 GATA50C03 2.0 # 107
36 1.2 # 107
38 1.2 # 107
40 5.6 # 107
42 6.3 # 106
43 D15S659 2.2 # 105
44 3.7 # 105
46 1.6 # 104
48 .0011
50 .0068
Chromosome 16:
50 .0070
51 D16S769 .0046
52 .0064
Chromosome 18:
3 GATA178F11 .0038
5 .0079
Chromosome 20:
84 .0069
86 .0041
88 .0034
90 D20S451 .0035
92 .0063
NOTE.—Distances are in Kosambi cM from the most telomeric p-
arm marker.
somes (chromosomes 1q31, 2p21, 4p16, 5q34, 9p24,
9q31, 10q26, 12q13, 12q23, 15q21, 16p12, 18p11,
and 20q13) with a nominal multipoint significance
level of , or LOD 1.18 (table 2). Our strong-P  .01
est evidence of linkage was observed on chromosome
15q with markers GATA50C03 and D15S659; mark-
er GATA50C03 exhibited a multipoint P value of
(empirical ; single-point7 51.98# 10 P  1.0# 10
) meeting criteria for highly significant7Pp 3.6# 10
linkage (Lander and Kruglyak 1995). This region on
chromosome 15q is novel. A weak linkage signal on
chromosome 15q was observed in our previous genome
scan (Schick et al. 2003). The remainder of the regions
demonstrated moderate evidence for linkage with mul-
tipoint P values ranging from .00016 to .0068. One
possible region of interest was located on chromosome
1q31, with the greatest significance at 196 cM (multi-
point ; empirical ; single-pointPp .0052 P  .0149
). Our results confirm previous reports of thisPp .0117
linkage on 1q31 (Klein et al. 1998a). Five markers on
chromosome 2 demonstrated evidence of linkage, with
marker D2S1356 having the greatest significance (mul-
tipoint ; empirical ; single-pointPp .0024 P  .0041
). This region on chromosome 2 has pre-4Pp 2.6# 10
viously been implicated in Doyne honeycomb dystrophy,
for which mutations in the EFEMP1 gene have been
discovered (Stone et al. 1999). We found suggestive ev-
idence of linkage on four other chromosomes 4, 5, 9,
and 10, at markers D4S3360 (multipoint ;Pp .0065
empirical ; single-point ), D5S1456P  .0087 Pp .0031
(multipoint ; empirical ; single-Pp .0021 P  .0049
point ), D9S1871 (multipoint ; em-Pp .0058 Pp .0032
pirical ; single-point ), D9S938P  .0048 Pp .0079
(multipoint ; empirical ; single-pointPp .0051 P  .008
), D10S1248 (multipoint ; empir-Pp .0017 Pp .0022
ical ; single-point ), respectively.P  .0037 Pp .0971
Linkage to 10q26 initially reported by Weeks et al.
(2001) for a binary ARMD trait, was recently confirmed
by Majewski et al. (2003), and now has been validated
in a quantitative trait linkage analysis for ARMD. How-
ever, the location of the linkage signals on chromosomes
5q34 and 9p24 are not identical to those reported else-
where (Weeks et al. 2001; Majewski et al. 2003). The
location of the second signal on chromosome 9 at
marker D9S938 is within 15–20 cM of the peak location
of the report of linkage at 9q33 by Majewski et al.
(2003) and represents a possible confirmation of this
linkage signal. Five markers in two possible regions of
linkage were also found on chromosome 12q13 and
12q23, with marker D12S2078 presenting the high-
est significance (multipoint ; empiricalPp .0019 P 
; single-point ). Marker D12S2078 is.002 Pp .0038
within 18 cM of markers D12S1300 and PAH, which
showed evidence of linkage in our previous community-
based sample (Schick et al. 2003). Finally, chromosomes
16, 18, and 20 also showed linkage evidence at markers
D16S769 ( ; empirical ; single-pointPp .0050 P  .0121
), GATA178F11 ( ; empiricalPp .0140 Pp .0047 P 
; single-point ), and D20S451 (.0033 Pp .0014 Pp
; empirical ; single-point ), re-.0034 P  .0052 Pp .0061
spectively. The last three loci are novel and are being
reported here for the first time.
Chromosome 15 Fine Mapping
Fine mapping was conducted on chromosome 15 us-
ing 14 new markers spanning the initial region. The
result, presented in figure 2, shows a clear confirmation
of the already overwhelmingly significant evidence of
linkage. Significant linkage evidence ( )5P ! 1.0# 10
extends over a 10-cM area on chromosome 15 contain-
ing four markers (table 3). The peak marker in this re-
gion is marker D15S1012 ( ). Our results7Pp 3.5# 10
are consistent with a major locus for ARMD suscepti-
bility on 15q.
Chromosome 12 Fine Mapping
We decided to fine-map the area of significance on
chromosome 12 indicated by our genome scan because
there was an overlap between this region and the result
discovered in the Beaver Dam ARMD genome scan
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Figure 2 Fine-mapping multipoint results on chromosome 15q for ARMD. Genetic distance (cM) is plotted on the X-axis against
(P value) on the Y-axis. Horizontal lines are drawn at and .pPp  log Pp .0001 Pp .00000110
(Schick et al. 2003). Thus, 25 additional markers on
chromosome 12 were added to the study using the ge-
netic distances provided at the Web site of the Marshfield
Center for Medical Genetics. On comparing the initial
genome scan results with the fine map and the previous
data from the BDES study, we observed a shift in the
linkage signal to a slightly more distal location. Figure
3 shows a region of 36.4 cM with five markers pre-
senting a significant link with ARMD at . TheP ! .01
peak marker is D12S2078 ( ) (table 3). How-Pp .0016
ever, markers D12S1300 and PAH, which were signifi-
cant in the previous study (Schick et al. 2003), did not
show any evidence of significant linkage, and it is pos-
sible that several ARMD loci reside on chromosome 12q.
Chromosome 1 Fine Mapping
A candidate gene for the exudative autosomal dom-
inant form of ARMD has been reported to be located
within a 9-cM region on chromosome 1q25-q31 be-
tween the markers D1S466 and D1S413 (Klein et al.
1998a). Because we obtained evidence of linkage with
marker D1S518, we also fine mapped a 12-cM region
that included markers D1S466, D1S518, D1S202,
D1S2625, D1S413, and D1S1660 (fig. 4 and table 3).
The linkage evidence ( ) extends over a 6.2-cMP  .01
area containing three markers (table 3), with marker
D1S202 on 1q31 showing the greatest significance
( ). Our results confirm previous reports ofPp .0014
linkage on 1q31 (Klein et al. 1998a). In summary, our
linkage analysis of ARMD provides strong evidence that
markers located on chromosomes 15, 12, and 1 dem-
onstrate linkage.
Family-by-Family Dissection of the Linkage Signals
To determine which families were linked to specific
chromosomes, we analyzed the largest 18 of the 34 fam-
ilies individually. The results of these linkage analyses
are presented in figure 5. We observed that most families
contributed to the linkage signal on more than one chro-
mosome (e.g., family 460), suggesting that, in these fam-
ilies, ARMD is an oligogenic disorder. Wiltshire et al.
(2002) showed how locus counting on genome scan data
can be used to determine that more regions demonstrate
evidence of linkage across a range of LOD scores than
would be expected by chance alone. For example, for a
typical autosomal genome scan with average marker
density of 10 cMs (15% missing genotypes), an inde-
pendent region of linkage with a LOD score of 1.51–
1.55 is expected to occur once by chance alone. We
observe that, in family 460, eight regions show P values
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Table 3
Genetic Locations and Multipoint P Values for Fine-Mapping
Markers and Interpolated Locations Showing Possible Linkage (P 
.01) on Chromosomes 1, 12, and 15 for ARMD
Chromosome and
Location (cM) Marker P Value
Chromosome 1:
200 .0079
201.6 D1S202 .0013
202 .0013
202.2 D1S518 .0020
204 .0016
206 .0050
206.2 D1S2625 .0070
Chromosome 12:
46 .0088
47 D12S1042 .0054
48 .0049
50 .0037
52 .0030
54 .0027
56 .0028
58 .0033
60 .0042
62 .0055
63 D12S297 .0056
64 .0066
66 .0087
119.6 D12S1344 .0048
119.6 D12S1583 .0027
120 .0024
122 .0014
124 .0014
125.3 D12S2070 .0018
126 .0015
128 9.5 # 104
130 6.9 # 104
132 6.8 # 104
134 9.1 # 104
136 .0015
136.8 D12S395 .0019
138 .0016
140 .0012
142 9.8 # 104
144 8.8 # 104
146 9.1 # 104
148 .0011
150 .0014
150 D12S2078 .0016
152 .0022
154 .0043
156 .0095
Chromosome 15:
25.9 D15S1007 .0035
26 .0026
28 4.5 # 104
28.4 D15S1040 4.2 # 104
30 3.0 # 105
32 3.5 # 106
32.6 D15S118 2.7 # 106
34 2.8 # 107
34.8 GATA50C03 2.8 # 107
(continued)
Table 3 (continued)
Chromosome and
Location (cM) Marker P Value
Chromosome 15 (continued):
36 D15S1012 3.5 # 107
36 2.7 # 107
38 5.0 # 108
40 6.7 # 107
40.3 D15S214 9.0 # 107
42 4.2 # 106
43.5 D15S659 3.3 # 105
44 4.7 # 105
45.6 D15S143 2.8 # 104
46 4.4 # 104
47.9 D15S209 .0030
48 .0030
50 .0047
51.2 D15S117 .0076
NOTE.—Distances are in Kosambi cM from the most telomeric p-
arm marker.
.0001, which supports the hypothesis of multigenic
inheritance.
Numerous families jointly contributed to linkage sig-
nals on chromosomes 9p, 12q, and 15q. In contrast,
only two families contributed very strongly to the link-
age signal on chromosome 10q26. Moreover, even on a
single chromosome, there is sizeable variance in the lo-
cation of the family-specific linkage signal (Cordell
2001). For example, over the region of 35–43 cM on
chromosome 15 that contains the location that shows
the strongest genomewide linkage evidence (36 cM;
), the results demonstrate that only fam-7Pp 3.5# 10
ily 446, 460, and 465 individually present evidence of
linkage at the level of significance. Other familiesP ! .01
do contribute to the linkage evidence, but the signal is
weaker and occasionally shifted, as seen in family 440.
We observe that the evidence from individual families
suggests that additional loci, not reaching statistical sig-
nificance when the data are analyzed as an aggregate,
may play a role in the pathogenesis of ARMD—for ex-
ample, the loci on chromosomes 7p, 13p, and 17q. Mul-
tiple weaker signals are observed on practically every
chromosome, which may simply be type 1 error or may
be the product of genetic modifiers of weak effect.
Heterogeneity Analysis
The presence of linkage heterogeneity among families
was tested at the following seven locations in the ge-
nome: 5q34, 9p24, 9q31, 10q26, 12q13, 12q23, and
15q21. The P values of the heterogeneity tests performed
at the initial locations of all seven regions are !.01. Fur-
thermore, these heterogeneity tests resulted in signifi-
cance at the 0.001 level in the five regions ranging from
164 to 175 cM on chromosome 5, from 0 to 10 cM and
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Figure 3 Fine-mapping multipoint results on chromosome 12q for ARMD. Genetic distance (cM) is plotted on the X-axis against
(P value) on the Y-axis. Horizontal lines are drawn at and .pPp  log Pp .01 Pp .00110
from 111 to 122 cM on chromosome 9, from 164 to
171 cM on chromosome 10 and from 30 to 43 cM on
chromosome 15. This analysis confirmed that there is
significant linkage heterogeneity among the pedigrees in
these regions (table 4). On the other hand, over the
regions from 56 to 68 cM on chromosome 2 and from
138 to 150 cM on chromosome 12, the P values for the
heterogeneity tests at some locations are 1.01. This result
does not strongly support the hypothesis of heteroge-
neity in these regions, contrary to the trends evident in
the pedigree-by-pedigree linkage analysis (table 5 and
fig. 5).
Epistasis Analysis
The most significant locations in the regions with
nominal linkage evidence of  are—apartPp .002
from 36 cM on chromosome 15—62 cM on chromo-
some 2, 170 cM on chromosome 5, 4 cM and 116 cM
on chromosome 9, 164 cM on chromosome 10, and 138
cM on chromosome 12. Each of these six locations was
tested in turn for epistatic interaction with the chro-
mosome 15 location. When the full regression model is
used, although no significant interactions are observed,
the significance of each individual locus is much reduced,
to the extent that for the locations on chro-P 1 .05
mosomes 9, 10, and 12. However, if no main effects are
fitted in the model, then the extremely small P values
for each one of the interaction terms (table 6) would
indicate that we cannot exclude genetic interaction be-
tween the location of 36 cM on chromosome 15 with
each of the locations listed above. These results indicate
extreme confounding and demonstrate that it is difficult
to find evidence for epistasis and that models of hetero-
geneity and epistasis may be irrevocably confounded in
this type of analysis.
Mutation Analysis of Candidate Genes
Sequencing exon 104 of hemicentin-1 in “affected”
individuals (i.e., those with ARMD scores 112) from
families linked to chromosome 1q31 ( ) did notNp 3
demonstrate any evidence of mutations in this exon. We
also sequenced all 11 exons of EFEMP1 in “affected”
family members from families linked to chromosome
2p16 ( ). No mutations were observed. To elimi-Np 3
nate hemicentin-1 and EFEMP1 as the putative suscep-
tibility genes, we also genotyped SNPs in these genes
and analyzed these SNPs as covariates in a linkage anal-
ysis. This analysis was performed in a subsample con-
taining the pedigrees linked to 1q31 and 2p16. Thus,
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Figure 4 Fine-mapping multipoint results on chromosome 1q for ARMD. Genetic distance (cM) is plotted on the X-axis against pPp
(P value) on the Y-axis. Horizontal lines are drawn at and . log Pp .01 Pp .00110
145 and 189 sib pairs were genotyped and analyzed for
hemicentin-1 and EFEMP1, respectively.
SNP Analysis
The following four SNPs within the hemicentin-1 gene
on chromosome 1q31 were analyzed: rs1475113 (H1),
rs743137 (H2), hCV625089 (H3), and rs680638 (H4).
First, standard linkage models without covariates—but
including the SNPs as outcome variables, to estimate
allele sharing at all locations—were constructed. Then,
as described in the “Methods” section, we simulta-
neously modeled all four SNPs in the Haseman-Elston
regression analysis as covariates (predictors), to deter-
mine if the SNPs were able to account for all the variance
at 1q31 and to explain the linkage results. We observed
that inclusion of the covariates associated with the dom-
inant effects led to numerical instability, because the
SNPs were located within the same gene and there is
significant colinearity involved when all 24 covariate
terms for the SNPs are included in the same model. Thus,
the dominance terms were excluded from the analyses,
leaving a total of 12 covariates in the full regression
equation.
Inclusion of the SNPs as markers in the linkage model
led to a significant increase in the overall evidence for
linkage at 1q31 (table 7). For example, at the location
of the SNP rs680638 (196.56 cM), the P value for link-
age obtained from a multipoint analysis that included
the SNPs as markers but did not include covariates is
7.2 # 105. We compared this model to those where
SNPs were sequentially dropped out of the analysis as
covariates (table 8). We observed a significant decline in
the level of significance when all 12 additive-effect cov-
ariates were included in the regression ( ), sug-Pp .51
gesting that inclusion of all four SNPs accounted for
virtually all the linkage evidence. Interestingly, the ad-
ditive-effect covariate terms from at least two SNPs was
necessary for the linkage P value to be 1.05. Among all
the combinations of the covariates corresponding to
three SNPs, the combination with SNPs rs1475113
(H1), rs743137 (H2), and rs680638 (H4) has the largest
P value ( ), suggesting that these three SNPs ac-Pp .44
count for the majority of the linkage. Among the two
SNP combinations, rs1475113 (H1) and rs680638 (H4)
shows the largest P value ( ). We also examinedPp .23
the haplotypic combinations that best accounted for the
significant results. Except for haplotypes of length 2, the
two methods described in the “Methods” section re-
sulted in the same susceptibility-associated haplotypes,
which can be seen, in table 8, to be consistent with each
Figure 5 Family-by-family multipoint results of the genomewide linkage scan for ARMD, using the Weber Panel 10 map spacing on 22
autosomes. Symbols corresponding to (P value) are presented for each of 18 families (family number on X-axis). For eachpPp  log10
chromosome, genetic distance (cM) is plotted on the Y-axis. Each box corresponds to a chromosome, with the chromosome number given in
the top left-hand corner.
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Table 4
Results of the Heterogeneity Analysis on Chromosomes 5, 9,
10, and 15, Demonstrating That Significant Familial
Variability Exists for ARMD
Chromosome
and Location
(cM) Marker Linkage F Test
Chromosome 5:
164 .0037 4 # 104
166 .0018 5 # 104
168 .0011 8.0 # 104
170 .0010 .0012
172 .0012 .0018
174 .0017 .0027
175 D5S1456 .0021 .0034
Chromosome 9:
0 D9S1779 .0057 !1 # 105
2 .0026 !1 # 105
4 .0018 !1 # 105
6 .0020 !1 # 105
8 D9S1871 .0032 !1 # 105
10 .0028 !1 # 105
111 D9S938 .0045 1 # 104
112 .0033 1 # 104
114 .0022 1 # 104
116 .0019 2 # 104
118 .0024 .0017
120 D9S930 .0038 !1 # 105
122 .0121 .0873
Chromosome 10:
164 .0024 2 # 104
165 D10S1248 .0022 3 # 104
166 .0017 3 # 104
168 .0012 4 # 104
170 .0013 4 # 104
171 D10S212 .0015 8 # 104
Chromosome 15:
32 3.9 # 107 !1 # 105
34 2.2 # 107 !1 # 105
35 GATA50C03 2.0 # 107 !1 # 105
36 1.2 # 107 !1 # 105
38 1.2 # 107 !1 # 105
40 5.6 # 107 !1 # 105
42 6.3 # 106 !1 # 105
NOTE.—The P values associated with the overall linkage test,
as well as these associated with the heterogeneity F statistic, are
shown.
Table 5
Results of the Heterogeneity Analysis on Chromosomes 2
and 12, Demonstrating That Little Significant Familial
Variability Exists for ARMD at These Loci
Chromosome
and Location
(cM) Marker Linkage F Test
Chromosome 2:
56 D2S1788 .0065 .2191
58 .0019 .1021
60 7.8 # 104 .0300
62 6.7 # 104 .0057
64 D2S1356 .0011 9 # 104
66 .0015 .0053
68 .0023 .0286
Chromosome 12:
138 .0031 .0109
140 .0021 .0061
142 .0015 .0043
144 .0012 .0051
146 .0012 .0097
148 .0014 .0184
150 D12S2078 .0019 .0264
NOTE.—The P values associated with the overall linkage
test, as well as these associated with the heterogeneity F
statistic are shown.
other. The haplotypes of length 2 associated with the P
value .2275 were different, and neither was consistent
with the haplotypes of length 1, 3, and 4. This leads us
to conclude that at least two SNPs, rs1475113 (H1) and
rs680638 (H4), and the corresponding haplotypes are
tightly associated with a causative variant (table 8).
Thus, the hemicentin-1 gene cannot be eliminated as a
candidate gene for ARMD. Interestingly, SNP rs680638
is located in intron 105, in close proximity to the original
reported mutation in exon 104 (Schultz et al. 2003).
Our sequencing analysis of the linked families excluded
exon 104; however, mutations in other nearby exons
cannot be eliminated as yet.
Two SNPs within the EFEMP1 gene, rs1430193 (E1)
and rs2277887 (E2), were targeted for analysis as cov-
ariates in a Haseman-Elston regression. The dominance
terms for both SNPs and the additive effects correspond-
ing to rs2277887 provided unstable estimates, and were
not included as covariates in the regression equation.
The most significant location for linkage on chromo-
some 2, after inclusion of the SNPs as markers (outcome
variable), but not as covariates, was at 89 cM on chro-
mosome 2 ( ) (table 9). There was no5Pp 7.3# 10
major difference in the P value for models with and
without the three additive-effect covariates correspond-
ing to rs1430193 (E1) ( without SNPs5Pp 7.3# 10
and with additive effect of SNP E1).5Pp 7.0# 10
Thus, addition of covariates (SNPs) did not take away
any linkage evidence at the most significant location on
chromosome 2, indicating that the EFEMP1 gene is nei-
ther partially causative nor tightly associated with a
causative gene. To further confirm this result, the linkage
signals on chromosome 2 obtained using multipoint
analyses were compared with and without the two SNPs.
When the SNPs were included in the analysis, the linkage
evidence generally become weaker (80 cM, )Pp .0023
near the EFEMP1 locus, as opposed to the linkage signal
without the SNPs (80 cM, ). This sup-5Pp 6.6# 10
ports our previous result that the EFEMP1 gene can be
eliminated as a candidate gene for ARMD.
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Table 6
Comparison of Allele Sharing (p-hat) in Models With and Without Epistasis Testing of Main Effects and Interaction Models
for Epistasis
CHROMOSOME
LOCATION
(cM)
P VALUE FOR MODEL
p-ia Alone
Main Effects Main Effects  Interaction
Interaction
Alonep-i p-15 p-i p-15 Interaction
2 62 6.7 # 104 5.9 # 104 1.1 # 107 .0493 .0018 .5406 5.5 # 108
5 170 9.7 # 104 .0041 4.7 # 107 .0462 .0052 .6667 9.6 # 108
9 4 .0018 .0071 4.5 # 107 .0097 1.6 # 104 .9113 1.9 # 106
9 116 .0019 .0059 3.5 # 107 .3458 .0270 .1909 6.6 # 108
10 164 .0012 .0025 2.4 # 107 .0521 .0013 .6625 3.4 # 107
12 138 .0012 .0040 3.8 # 107 .1612 .0190 .3754 3.8 # 108
a p-i p the average allele sharing at a locus other than chromosome 15, i p 2, 5, 9, 10, and 12.
Table 7
Summary of Linkage Analysis Results With and Without
the Four SNPs in Hemicentin-1
LOCATION
(cM) MARKER
P VALUE
Without SNPs With SNPs
20 .0099 .0111
21 .0097 .0107
22 .0095 .0103
23 .0095 .0101
24 .0096 .0099
25 .0097 .0098
26 .0099 .0098
27 .0102 .0098
28 .0106 .0100
194 .0058 .0026
195 .0029 9.4 # 104
196 .0016 4.1 # 104
197 9.7 # 104 2.6 # 104
198 7.2 # 104 2.4 # 104
199 6.6 # 104 3.2 # 104
200 7.2 # 104 5.2 # 104
200.32 rs1475113 6.2 # 104
200.4 rs743137 6.0 # 104
200.48 hCV625089 1.3 # 104
200.56 rs680638 7.2 # 105
201 9.1 # 104 1.3 # 104
202 .0012 7.0 # 104
202.1 D1S518 .0014 .0016
203 .0016 .0017
204 .0019 .0021
205 .0024 .0026
206 .0032 .0036
207 .0047 .0052
208 .0072 .0079
Discussion
In this study, we have successfully mapped a novel major
locus and oligogenic determinants for ARMD suscep-
tibility, by use of sib-pair allele-sharing methods in ex-
tended families. We have identified novel loci on chro-
mosomes 15q21, 5q34, 9p24, 12q13, 16p12, 18p11,
and 20q13. Because of the availability of larger families,
we were able to widen the scope of the allele-sharing
methods to investigate 18 of the largest families indi-
vidually. Examination of these results led us to conclude
that ARMD pathogenesis is determined by locus het-
erogeneity and/or epistatic interaction between multiple
susceptibility loci.
When we tested for evidence of heterogeneity at the
seven loci that showed most evidence for linkage, we
obtained significant support for this hypothesis at 5q34,
9p24, 9q31, 10q26, and 15q21. We investigated the
epistatic interaction between the major locus on 15q21
and other minor loci on chromosomes 2p21, 5q34,
9p24, 9q31, 10q26, and 12q23. A full model for epis-
tasis between two loci includes four epistatic compo-
nents of variance (additive# additive, additive# dom-
inant, dominant # additive, and dominant # domi-
nant) (Tiwari and Elston 1997). However, to increase
power, we included in our epistasis model only one of
these four components, because there is a large degree
of confounding among them. This is analogous to our
including an additive genetic component, rather than
both additive and dominant genetic components (which
are also largely confounded) in our models without epis-
tasis. Nevertheless, we initially found no significant ev-
idence for epistasis. On the other hand, the significance
of the individual locus variance components was greatly
reduced in this analysis, and there was highly significant
evidence for epistasis in a model that did not include
any single-locus variance components, indicating con-
founding between the single- and two-locus compo-
nents. Epistasis was also proposed by Majewski et al.
(2003) in a recent model-based ARMD linkage scan in
70 families (344 affected and 217 unaffected). These
investigators tested for epistatic interaction between
markers at 3p13 and 10q26 and observed significant
results. Although we did not test for interaction between
markers at 3p13 and 10q26, our investigation on epis-
tasis suggests that it may not be feasible to differentiate
between models of epistasis and heterogeneity with this
type of analysis. Thus far, very few moieties with an
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Table 8
Modeling of Four SNPs in Hemicentin-1 as Covariates in the
Haseman-Elston Regression
NO. OF SNPS
AND MODEL P VALUE
ASSOCIATED
HAPLOTYPEa
H1 H2 H3 H4
0:
Without Covariates 7.2 # 105
4:
12 additive effects .5147 G A T T
3:
Additive effects of H2H3H4 .1242
Additive effects of H1H3H4 .2925
Additive effects of H1H2H4 .4400 G A T
Additive effects of H1H2H3 .3755
2:
Additive effects of H1H2 .0368
Additive effects of H1H3 .1436
Additive effects of H1H4 .2275 A T
Additive effects of H2H3 .0116
Additive effects of H2H4 .0761
Additive effects of H3H4 .0566
1:
Additive effects of H1 .0032
Additive effects of H2 9.0 # 104
Additive effects of H3 .0181
Additive effects of H4 .0446 T
NOTE.—Models ranging from inclusion of all SNPs (12 additive
effects) to those with only a single SNP were tested.
a H1 p SNP rs1475113, H2 p SNP rs743137, H3 p SNP
hCV625089, and H4 p SNP rs680638.
Table 9
Summary of Linkage Analysis Results With and Without
the Two SNPs in EFEMP1
LOCATION
(cM) MARKER
P VALUE
Without SNPs With SNPs
56 D2S1788 .0073 .0076
57 .0046 .0049
58 .0030 .0032
59 .0020 .0022
60 .0014 .0016
61 .0011 .0013
62 9.4 # 104 .0011
63 8.6 # 104 9.9 # 104
64 D2S1356 8.4 # 104 9.7 # 104
65 8.1 # 104 9.6 # 104
66 7.9 # 104 9.6 # 104
67 7.8 # 104 9.8 # 104
68 7.8 # 104 .0010
69 7.9 # 104 .0011
70 8.1 # 104 .0012
71 8.6 # 104 .0013
72 9.3 # 104 .0015
73 .0010 .0018
74 D2S1352 .0011 .0021
75 6.6 # 104 .0019
76 3.8 # 104 .0018
77 2.3 # 104 .0017
78 1.4 # 104 .0018
79 9.1 # 105 .0020
80 6.6 # 105 .0023
80.61 rs1430193 .0025
80.62 rs2277887 .0025
81 5.3 # 105 .0018
82 4.8 # 105 8.2 # 104
83 4.7 # 105 3.9 # 104
84 5.1 # 105 2.1 # 104
85 5.9 # 105 1.4 # 104
86 7.1 # 105 1.1 # 104
87 D2S441 8.8 # 105 1.1 # 104
88 6.0 # 105 7.8 # 105
89 5.4 # 105 7.3 # 105
90 7.1 # 105 9.6 # 105
91 D2S1394 1.3 # 104 1.8 # 104
92 1.2 # 104 1.6 # 104
93 1.3 # 104 1.6 # 104
94 1.4 # 104 1.7 # 104
95 1.7 # 104 2.0 # 104
96 2.3 # 104 2.6 # 104
97 3.4 # 104 3.7 # 104
98 5.6 # 104 5.8 # 104
99 9.5 # 104 9.7 # 104
100 .0017 .0017
101 .0029 .0028
102 .0049 .0048
103 D2S1790 .0079 .0077
104 .0101 .0098
established role in ARMD are known that could drive
the search for specific biological interactions, giving
context to the epistatic (statistical) interactions identi-
fied in either our or other genome scans.
At the location of each linkage signal we canvassed
the literature for genes known to play a role in ARMD
and its clinical variants. Thus, in an effort to implicate
specific candidate genes at 1q31 and 2p21, we tested
SNPs at the hemicentin-1, and EFEMP1 genes, respec-
tively. EFEMP1 is a member of the fibulin family (Timpl
et al. 2003), a versatile group of extracellular matrix
proteins. Mutations in EFEMP1 cause misfolding of the
protein, followed by inefficient secretion of the mutant,
which triggers accumulation of EFEMP1 in the RPE
(Marmorstein et al. 2002). Although, EFEMP1 accu-
mulates in the RPE, it is not a major component of
drusen and the precise mechanism for drusen formation
and culmination in advanced forms of Malattia Lev-
entinese and Doyne honeycomb dystrophy (Stone et al.
1999; Guymer et al. 2002) is unknown. Both disorders
are characterized by early-onset drusen formation with
radial patterning of the drusen in the macula. Hemi-
centin-1 was identified as a positional candidate on
1q31 by Schultz et al. (2003) because of its similarity
to EFEMP1, after 30 genes in the region were scanned.
Hemicentin-1 is a conserved extracellular member of
the immunoglobulin superfamily (Vogel and Hedgecock
2001). Mutations in the him-4 locus, a Caenorhabditis
elegans hemicentin ortholog, lead to tissue frailty and
cell migration defects (Vogel and Hedgecock 2001).
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Hemicentin-1 has been nominated as the ARMD1 locus,
with mutations in exon 104 postulated to cause ARMD
pathogenesis (Schultz et al. 2003).
Our SNP analysis suggests that variants in hemicen-
tin-1, but not in EFEMP1, are tightly linked to an
ARMD locus. We observed that the best-fitting model
that accounted for a significant proportion of the link-
age signal on 1q31 required a minimum of two SNPs.
Of the four SNPs examined in hemicentin-1, SNPs
rs1475113 (H1) and rs680638 (H4), located in introns
4 and 105, respectively, jointly explain the majority of
the 1q31 linkage signal (table 8). When examining each
SNP singly, we observed that rs680638 (H4) accounted
for most of the linkage signal. The location of this SNP,
between exons 104 and 105 in this large gene (transcript
length 18,018 base pairs, 107 exons) is of considerable
interest because of the initial report of mutations in exon
104 of hemicentin-1 causing ARMD1 (Schultz et al.
2003). Although we were unable to confirm the mu-
tation in exon 104 via sequencing of affected individuals
in the linked families, the ARMD susceptibility variant
is likely to be in close proximity to this SNP. Our anal-
ysis indicates that a gene other than EFEMP1 at 2p21
is responsible for ARMD susceptibility. Because ARMD
is oligogenic, with perhaps 8–10 predisposing loci, an
exhaustive search at each linkage signal may involve
analysis of innumerable candidate genes. We have pre-
sented an efficient strategy using SNPs as screening tools
to limit the number of genes that would need to be
scanned for specific mutations.
Comparison of our overall genome scan results with
other published data reveals that we have novel results,
but can also confirm several other linkage reports. Our
group is the first to report the locus on chromosome
15q21. Of the other signals on chromosomes 1q31, 2p21,
4p16, 5q34, 9p24, 9q31, 10q26, 12q13, 12q23, 16p12,
18p11, and 20q13, the locations on 1q31, 2p21, 9p24,
9q31, 10q26, 12q23, and 16p12 have been reported in
previous genome scans (Weeks et al. 2000, 2001; Ma-
jewski et al. 2003; Schick et al. 2003; Schmidt et al. 2003;
Seddon et al. 2003). Family-by-family analysis (fig. 5)
confirms the presence of these multiple loci and has un-
covered signals on other chromosomes (e.g., 4q, 7p, 13p,
and 17q) that may contribute to ARMD pathogenesis.
The loci on chromosomes 4q and 17q have been de-
scribed by other groups (Weeks et al. 2000, 2001; Ma-
jewski et al. 2003), but the other two are original reports.
In general, our analysis has captured most of the previous
linkage signals in addition to discovering new loci. We
attribute our ability to identify novel signals and to cross-
validate previously documented linkage to the use of a
quantitative system with all levels of phenotypic severity,
as opposed to a binary phenotype.
Thus, cross-validated loci on chromosomes 1q31,
9p24, 9q31, 10q26, 12q23, 16p12 and 17q25 are prob-
ably associated with advanced forms of the disease, be-
cause these loci were primarily identified through affected
sib pair analysis. Our locus on chromosome 15q may
predispose to drusen formation because it is present in
both our genome scans. As described in the introduction,
the previous genome scan for ARMD was based on
milder forms of the disorder since the genotyped Beaver
Dam sample was ascertained from a larger community-
based sample which represented all levels of severity
(Schick et al. 2003). At this juncture the observations
pertaining to specific phenotypes driving particular link-
age signals are merely speculative. Specific information
on phenotypic diversity from other studies has not
emerged to develop better-formulated hypotheses.
The proportion of families linked to 1q31 is disputed
to range between 7–15% (Majewski et al. 2003) and
40% (Weeks et al. 2001). Our data support fewer fam-
ilies being linked to 1q31, although any estimate is sub-
ject to ascertainment bias. Further, not each family con-
tributes equally to the linkage signal, and weak but
pervasive modifier effects at the 1q31 locus cannot be
presently eliminated.
Our family-by-family analysis has implications for
the use of subsets or covariate analysis to enrich samples
to detect weaker linkage signals. While these methods
are useful to enhance linkage signals by reducing het-
erogeneity, they may unwittingly exclude particular ep-
istatic interactions that are important in the etiology of
the disease. These types of assumptions would have the
greatest impact for diseases that are truly oligogenic in
nature, as is ARMD. Contingent on the availability of
extended families, we present an exploratory method
that uses family-specific sib-pair allele sharing to assess
which families contribute to the linkage signals at a
particular locus. This method makes no assumption
about the specific genetic model at any locus, and so
may be more appropriate than assessing the heteroge-
neity fraction in a model-based analysis to determine
the identity of linked families and the signal strength of
this linkage in any given family. For example, at 10q26,
two families, 454 and 460, contribute heavily to the
linkage signal ( per family), although at leastP ! .0001
5 or 6 others demonstrate weak linkage (fig. 5). The
discovery of these “strongly linked” families can now
drive identification of haplotypes and mutations by use
of more established methods.
One limitation of the above method is that the family-
specific analysis can only be reliably conducted on ex-
tended families, which are seldom collected for multi-
factorial diseases. Other weaknesses of this method
include the use oflog10 P value (pP) as a direct measure
of the linkage signal strength in each family without
appropriate adjustment for family size. Since, for LOD
10.5, the quantity pP is virtually linear in LOD (when
only 1 df is involved) and the LOD is proportional to
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the number of informative sib pairs per family, pP/(fam-
ily size) may provide a better comparative measure.
Thus, after adjustment for family size, smaller families
will be weighted appropriately for the corresponding
reduction in linkage evidence, but reliable exclusion of
linkage may remain problematic for these families. This
is an area that needs further theoretical investigation.
Finally, because of the combinatorial possibilities in-
volving 110 loci, the phenotype-genotype correlations
will not be easy to establish for ARMD, even if mu-
tations are identified in some positional candidates.
These difficulties will also follow when meta-analyses
are proposed to boost weak linkage signals in multiple
data sets. Conversely, linkage evidence in a single family
led to identification of a putative candidate locus for
ARMD1, namely hemicentin-1. Our family-by-family
analysis and data published by other groups (Majewski
et al. 2003; Schmidt et al. 2003) suggests that other
such families exist for ARMD that may aid in positional
cloning of these loci. We anticipate that the cloning of
these loci will lead to important biological information
on the RPE and its pathophysiology, which will help in
constructing hypotheses on phenotype-genotype corre-
lations for this complex disease.
In summary, our results suggest that the etiology of
ARMD is multifactorial. Significant progress has been
made by our group in identifying a major locus for
ARMD pathophysiology on 15q and in confirming link-
age reports at several other loci. We are also able to
provide supporting evidence for hemicentin-1 as the
ARMD1 locus by use of SNP analysis. In the future,
we hope to be able to delineate the role of candidate
genes on ARMD at other loci, including 15q, and to
construct models for these genes that include their func-
tional characteristics.
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